Post by rickrick on Apr 17, 2015 19:43:15 GMT
I've noticed for sometime that stem cells seem to get the back burner when it comes to media attention. It could just be my imagination 
One thing that I thought odd a few years back is why Michael J Fox went away from stem cells and started supporting gene therapy. I would think his interest would/could/should orient towards the most viable option out there since he has a disease that needs curing.
I've also touted for years that big pharma will decide when and where stem cells get their day and I still believe this. Reading over the latest FierceBiotech.com page (http://www.fiercebiotech.com/?utm_medium=nl&utm_source=internal) I stay convinced.
BioTech is still booming and getting more support than ever, unfortunately when I look around, their definitions seem to always lean towards drug oriented biotech which is why I see gene therapy getting more attention.
Reading this definition of Gene Therapy (https://en.wikipedia.org/wiki/Gene_therapy), I see where big pharma could manipulate this therapy to make it more like a drug. That is, control it in a way to where they can affect diseases to a point where the disease is not cured but helped so that money from the treatments can continue to come in as opposed to stem cell therapy that may possibly 'cure' the disease thereby stopping the money flow.
Any thoughts on this theory?
One thing that I thought odd a few years back is why Michael J Fox went away from stem cells and started supporting gene therapy. I would think his interest would/could/should orient towards the most viable option out there since he has a disease that needs curing.
I've also touted for years that big pharma will decide when and where stem cells get their day and I still believe this. Reading over the latest FierceBiotech.com page (http://www.fiercebiotech.com/?utm_medium=nl&utm_source=internal) I stay convinced.
BioTech is still booming and getting more support than ever, unfortunately when I look around, their definitions seem to always lean towards drug oriented biotech which is why I see gene therapy getting more attention.
Reading this definition of Gene Therapy (https://en.wikipedia.org/wiki/Gene_therapy), I see where big pharma could manipulate this therapy to make it more like a drug. That is, control it in a way to where they can affect diseases to a point where the disease is not cured but helped so that money from the treatments can continue to come in as opposed to stem cell therapy that may possibly 'cure' the disease thereby stopping the money flow.
Any thoughts on this theory?
